Atish Gheware

Research Scientist@AIIMS | Pharmacist| Molecular Biologist | @CSIR-IGIB alumnus | works on hypoxia, mitochondria, network pharmacology, and lung disorder

[Ritu chauhan @Ritu__Chauhan]

Do you know how our traditional Ayurveda science helps us to understand inter-individual heterogeneity? Our latest research show how it would be
https://t.co/37cGyUq3GG
Also featured in Pulse, @IGIBSocial's online magazine.
https://t.co/hYlR8ojgVu
@aiims_nd @moayush @AcSIR_India

[Ritu chauhan @Ritu__Chauhan]

I am very excited to share that a part of my Ph.D. thesis got published in Physiological Reports today.
"This study shows that the generalized approach is not fit for all where the response to a condition such as stress or treatment is concerned"
https://t.co/KMi1dz5MgR

[Sangeetha K @sangee_felix]

Showcasing CSIR-IGIB Ayurgenomics Research to WHO Global Centre for Traditional Medicine delegates led by Dr Shyama Kuruvilla on 19th July 2022. WHO-TDR Director Dr John Reeder also participated in the discussion.
@WHO @IGIBSocial @TDRnews
@1hemantkgautam @BRPrasher (1/1)

[DMM Journal @DMM_Journal]

In our latest Editor's Choice, @djaiims &team @aiims_newdelhi describe distinct lung transcriptomes in #COVID19 patients from India:

💡https://t.co/blw6ADmq2N
📰https://t.co/QOsshBOGNB
@AtishGheware #OpenAccess

[Nathan A. Pennell MD, PhD, FASCO @n8pennell]

Most pts w/ #lungcancer reside in low- & middle-income countries, where incidence continues to increase. Accessibility, availability, & affordability are key domains in barriers to access of care. https://t.co/yuDbJPbO98 #ASCOEdBook #LCSM @AtishGheware @djaiims #ASCO22

[Atish Gheware @AtishGheware]

I am excited to share our recent research indicating that COVID-19 mortality is driven by two distinct trajectories
# COVID-19 #Cytokine Release Syndrome-rare signature #metatranscriptome #Lung tissue

https://t.co/SVddslxQqs

[Atish Gheware @AtishGheware]

Our recent research demonstrates the pathobiological role of ACE2 expression in COVID-19 severity

https://t.co/83b0gIXCwN

[Atish Gheware @AtishGheware]

Delighted to share our recent review on the barriers to accessing care along the continuum for lung cancer

https://t.co/bcDSr5xG33

[Atish Gheware @AtishGheware]

Check out our #preprint on @researchsquare: ACE2 expression in lungs of severe COVID-19 infection: a study on minimally invasive post-mortem tissue samples

[Research Square Covid-19 Preprints @RS_COVID19]

ACE2 Expression in Lungs of Severe COVID-19 Infection: A Study on Minimally Invasive Post- mortem Tissue Samples #covid https://t.co/GdhYP5I8CJ

[Research Square Covid-19 Preprints @RS_COVID19]

ACE2 Expression in Lungs of Severe COVID-19 Infection: A Study on Minimally Invasive Post- mortem Tissue Samples #covid https://t.co/GdhYP5I8CJ

[SP Kalantri @spkalantri]

1/n
#COVAXIN trial preprint was published few hours ago. Here is my summary of the trial- over 7 slides.

How was the trial designed?

[CSIR-IGIB @IGIBSocial]

On this #IGIB Foundation Day, @mukerjim will be delivering the annual AP Joshi Memorial Lecture.

[Anurag Agrawal @AnuragAgrawalMD]

Glad to see global interest in this highly innovative new application of #CRISPR by @Debojyoti_C @souvik_csir. Initial clinical sample data submitted to @ICMRDELHI and moving to limited clinical deployment and testing. @IGIBSocial @CSIR_IND @kvijayraghavan @drharshvardhan

[Eric Topol @EricTopol]

How many studies are needed before we accept that people with prior covid-19 have a robust immune Ab response to a single dose of mRNA vaccines, like the 2nd dose for those with no prior covid?
https://t.co/m4TbTaigwb
https://t.co/qwqvC6xmMn
https://t.co/eK2XqKJkvB

[Prof. Akiko Iwasaki @VirusesImmunity]

Here is a great thread related to this by @MonicaGandhi9 👇🏽 (8/n)

https://t.co/FhAiBAnj99

[Eran Segal @segal_eran]

Israel:

1.95 million vaccinated (~22% pop.)

~76% of all 60+ years old

First signs of efficacy:

2-weeks after 30% of 60+ vac., drop of 25% in % of 60+ critically ill out of all cases

Cities with higher vac. rates have fewer critically ill

But many caveats and issues

>>>

[Prof. Akiko Iwasaki @VirusesImmunity]

This work by @WilenLab @chennifer_jen @StephanieEisen shows non-steroidal anti-inflammatory drugs (NSAIDs) dampen antibody response to #SARSCoV2 in mice. Important implications.

https://t.co/GTyh6jfx5p

[Vinod Scaria @vinodscaria]

SpiceHealth, @IGIBSocial set up genome testing lab at Delhi's IGI Airport . Read more : https://t.co/IJ8dBJHzIa

@CSIR_IND #CSIRfightsCOVID19 @Rakesh_IGIB @taneja_bhupesh @AnuragAgrawalMD @RajeshPandey @spice_health

[Eric Topol @EricTopol]

One per thousand Americans have now died from covid-19.
How does that compare with 12 other select countries with >20 million population?

[Eric Topol @EricTopol]

At least the mechanism is simple 😉